The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens proteins
Authors:
- John J. HardingJHJohn J. Harding
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 50 (5) , 463-467
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The major metabolite of bendazac inhibits the glycosylation of soluble lens proteins: A possible mechanism for a delay in cataractogenesisExperimental Eye Research, 1988
- Non-enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathioneExperimental Eye Research, 1988
- Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylationLife Sciences, 1988
- Conformational changes induced in lens α- and γ-crystallins by modification with glucose 6-phosphate. Implications for cataractBiochemical Journal, 1987
- Bendazac prevents cyanate binding to soluble lens proteins and cyanate-induced phase-separation opacities in vitro: a possible mechanism by which bendazac could delay cataractExperimental Eye Research, 1986
- Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-LinkingScience, 1986
- DO ASPIRIN-LIKE ANALGESICS PROTECT AGAINST CATARACT?: A Case-control StudyThe Lancet, 1986
- Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: A possible mechanism by which aspirin could prevent cataractExperimental Eye Research, 1985